Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low-Grade Serous Ovarian Cancer × Gynecologic × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 721 Uterine Cervical Neoplasms 475 Endometrial Neoplasms 425 Fallopian Tube Neoplasms 194 Breast Neoplasms 194 Colorectal Neoplasms 146 Carcinoma, Non-Small-Cell Lung 144 Neoplasms 124 Stomach Neoplasms 113 Pancreatic Neoplasms 107 Melanoma 94 Prostatic Neoplasms 90 Lung Neoplasms 89 Neoplasm Metastasis 84 Triple Negative Breast Neoplasms 81 Carcinoma, Ovarian Epithelial 79 Urinary Bladder Neoplasms 75 Squamous Cell Carcinoma of Head and Neck 72 Head and Neck Neoplasms 69 Esophageal Neoplasms 68 Carcinoma, Renal Cell 63 Vulvar Neoplasms 54 Uterine Neoplasms 54 Uterine Cervical Dysplasia 52 Peritoneal Neoplasms 48 Colonic Neoplasms 48 Sarcoma 47 Carcinoma, Hepatocellular 47 Papillomavirus Infections 44 Carcinoma, Transitional Cell 38

Interventions

defactinib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06394804 2026-02-03

CHAMELEON

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Low-Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡